PRMT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Restoration of PRMT1WT but not PRMT1E153Q reversed Prmt1 KO‐mediated reductions of the leukemia burden and the percentages of LSPCs in BM and spleen of secondary CML mice (Figure 3F–L).